Fracture healing: From basic science to role of nutrition

Frontiers in Bioscience - Landmark

Volumn 19, Issue 7, 2014, Pages 1162-1175

  Giganti, Maria Gabriella ^a   Tresoldi, Ilaria ^a   Masuelli, Laura ^b   Modesti, Andrea ^a   Grosso, Giuseppe ^c   Liuni, Federico Maria ^a   Celi, Monica ^a   Rao, Cecilia ^a   Gasbarra, Elena ^a   Bei, Roberto ^a   Tarantino, Umberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Fracture healing; Inflammation; Nutritional factors; Osteoporosis; Review

Indexed keywords

AUTACOID; CYTOKINE;

AGING; BIOLOGICAL MODEL; BONE REMODELING; FRACTURE; FRACTURE HEALING; FRAGILITY FRACTURE; HUMAN; METABOLISM; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; BONE REMODELING; CYTOKINES; FRACTURE HEALING; FRACTURES, BONE; HUMANS; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OSTEOPOROTIC FRACTURES;

EID: 84904568851     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4273     Document Type: Article

References (144)

1. M. M. Sandberg, T. A. Hannu, E. I. Vuorio: Gene expression during bone repair. Clin Orthop 289, 292-312 (1993) (Pubitemid 23124826)
2. D. R. Marsh, G. Li: The biology of fracture healing: optimising outcome. Br Med Bull 55, 856-69 (1999) (Pubitemid 30011819)
3. G. L. Barnes, P. J. Kostenuik, L. C. Gerstenfeld, T. A. Einhorn: Growth factor regulation of fracture repair. J Bone Miner Res 11, 1805-1815 (1999) (Pubitemid 29521774)
4. T. Kon, T. J. Cho, T. Aizawa, M. Yamazaki, N. Nooh, D. Graves, L. C. Gerstenfeld, T. A. Einhorn: Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16, 1004-1014 (2001) (Pubitemid 32467144)
5. L. C. Gerstenfeld, D. M. Cullinane, G. L. Barnes, D. T. Graves, T. A. Einhorn: Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88, 873-884 (2003) (Pubitemid 36337032)
6. T. A Einhorn: The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355, S7-21 (1998)
7. K. Oe, M. Miwa, Y. Sakai, S. Y. Lee, R. Kuroda, M. Kurosaka: An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity. J Bone Joint Surg Br 89, 133-138 (2007) (Pubitemid 46218428)
8. R. Bielby, E. Jones, D. McGonagle: The role of mesenchymal stem cells in maintenance and repair of bone. Injury 38:S26-32 (2007) (Pubitemid 46440927)
9. G. Grosso, R. Bei, A. Mistretta, S. Marventano, G. Calabrese, L. Masuelli, M. G. Giganti, A. Modesti, F. Galvano, D. Gazzolo: Effects of vitamin C on health: a review of evidence. Front Biosci (Landmark Ed) 1, 1017-1029 (2013)
10. V. Izzi, L. Masuelli, I. Tresoldi, P. Sacchetti, A. Modesti, F. Galvano, R. Bei: The effects of dietary flavonoids on the regulation of redox inflammatory networks. Front Biosci (Landmark Ed) 1, 2396-2418 (2012)
11. T. J. Cho, L. C. Gerstenfeld, T. A. Einhorn: Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17, 513-520 (2002) (Pubitemid 34171766)
12. T. A. Einhorn, R. J. Majeska, E. B. Rush, P. M. Levine, M. C. Horowitz: The expression of cytokine activity by fracture callus. J Bone Miner Res 10:1272-1281 (1995)
13. C. Ferguson, E. Alpern, T. Miclau, J. A. Helms: Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87, 57-66 (1999) (Pubitemid 29428086)
14. R. Dimitriou, E. Tsiridis, P. Giannoudis: Current concepts of molecular aspects of bone healing. Injury Int J Care Injured 36, 1392-1404 (2005) (Pubitemid 41618169)
15. P. Giannoudis, T. A. Einhorn, D. Marsh: Fracture healing: The diamond concept. Injury Int J Care Injured 38, S3-S6 (2007) (Pubitemid 351162866)
16. B. McKibbin: The biology of fracture healing in long bones. J Bone Joint Surg [Br] 60, 150-162 (1978) (Pubitemid 8356852)
17. Z. S. Al-Aql, A. S. Alagl, D. T. Graves, L. C. Gerstenfeld, T. A. Einhorn: Molecular mechanisms controlling bone formation during fracture healing and distraction. Osteogenesis J Dent Res 87, 107-118 (2008)
18. C. A. Stone: A molecular approach to bone regeneration. Br J Plast Surg 50, 369-373 (1997) (Pubitemid 27312148)
19. P. J. Harwood, J. B. Newman, A. Michael: An update on fracture healing and non-union. Orthopaedics and Trauma 24, 9-23 (2010)
20. L. Masuelli, G. Tumino, M. Turriziani, A. Modesti, R. Bei: Topical use of sucralfate in epithelial wound healing: clinical evidences and molecular mechanisms of action. Recent Pat Inflamm Allergy Drug Discov 4, 25-36 (2010)
21. I. H. Kalfas: Principles of bone healing. Neurosurg Focus 10, E1 (2001)
22. M. M. L. Deckers, R. L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van der Bent, S. E. Papapoulos, C. W. Löwik: Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545-1553 (2002) (Pubitemid 34274386)
23. E. Zelzer, D. J. Glotzer, C. Hartmann, D. Thomas, N. Fukai, S. Soker, B. R. Olsen: Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106, 97-106 (2001) (Pubitemid 32701077)
24. A. Schindeler, M. M. McDonald, P. Bokko, D. G. Little: Bone remodeling during fracture repair: The cellular picture. Semin Cell Dev Biol 19, 459-466 (2008)
25. H. Peng, A. Usas, A. Olshanski, A. M. Ho, B. Gearhart, G. M. Cooper, J: Huard: VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017-2027 (2005) (Pubitemid 41532787)
26. T. Tarkka, A. Sipola, T. Jämsä, Y. Soini, S. Ylä-Herttuala, J. Tuukkanen, T. Hautala: Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5, 560-566 (2003) (Pubitemid 40310399)
27. K. Stoffel, H. Engler, M. Kuster, W. Riesen: Changes in biochemical markers after lower limb fractures. Clin Chem 53, 131-134 (2007) (Pubitemid 46047773)
28. S. Harada, G. A. Rodan: Control of osteoblast function and regulation of bone mass. Nature 423, 349-355 (2003) (Pubitemid 40852710)
29. S. L. Teitelbaum, F. P. Ross: Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638-649 (2003) (Pubitemid 36917505)
30. X. Fan, D. M. Biskobing, D. Fan, W. Hofstetter, J. Rubin: Macrophage colony stimulating factor downregulates MCSF-receptor expression and entry of progenitors into the osteoclast lineage. J Bone Miner Res 12, 1387-1395 (1997) (Pubitemid 27375381)
31. Y. Y. Kong, H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, J. M. Penninger: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323 (1999)
32. T. Braun, J. Zwerina: Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther 13, 235 (2011)
33. W. J. Boyle, W. S. Simonet, D. L. Lacey: Osteoclast differentiation and activation. Nature 423, 337-342 (2003) (Pubitemid 40852708)
34. A. Neve, A. Corrado, F. P. Cantatore: Osteocytes: central conductors of bone biology in normal and pathological conditions. Acta Physiol (Oxf) 204, 317-330 (2012)
35. S. L. Teitelbaum: Bone resorption by osteoclasts. Science 289, 1504-1508 (2000)
36. J. P. David, G. Schett: TNF and Bone. Curr Dir Autoimmun Basel 11, 135-144 (2010)
37. L. F. Bonewald, M. L. Johnson: Osteocytes, mechanosensing and Wnt signaling. Bone 42, 606-615 (2008)
38. C. Galli, G. Passeri, G. M. Macaluso: Osteocytes and WNT: the mechanical control of bone formation. J Dent Res 89, 331-343 (2010)
39. C. Vincent, D. M. Findlay, K. J. Welldon, A. R. Wijenayaka, T. S. Zheng, D. R. Haynes, N. L. Fazzalari, A. Evdokiou, G. J. Atkins: Pro-inflammatory cytokines TNFrelated weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen activated protein kinase (MAPK) - Dependent Expression of Sclerostin in Human Osteoblasts. J Bone Miner Res 24, 1434-1449 (2009)
40. M. E. Brunkow, J. C. Gardner, N. J. Van, B. W. Paeper, B. R. Kovacevich, S. Proll, J. E. Skonier, L. Zhao, P. J. Sabo, Y. Fu, R. S. Alisch, L. Gillett, T. Colbert, P. Tacconi, D. Galas, H. Hamersma, P. Beighton, J.. Mulligan: Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589 (2001) (Pubitemid 32202753)
41. T. Nakashima, M. Hayashi, T. Fukunaga, K. Kurata, M. Oh-Hora, J. Q. Feng, L. F. Bonewald, T. Kodama, A. Wutz, E. F. Wagner, J. M. Penninger, H. Takayanagi: Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17, 1231-1234 (2011)
42. J. Xiong, M. Onal, R. L. Jilka, R. S. Weinstein, S. C. Manolagas, C. A. O'Brien: Matrix embedded cells control osteoclast formation. Nat Med 17, 1235-1241 (2011)
43. T. Moriishi, Z. Maruyama, R. Fukuyama, M. Ito, T. Miyazaki, H. Kitaura, H. Ohnishi, T. Furuichi, Y. Kawai, R. Masuyama, H. Komori, K. Takada, H. Kawaguchi, T. Komori: Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis. PLoS One 6:e27487 (2011)
44. G. Gu, M. Mulari, Z. Peng, T. A. Hentunen, H. K. Vaananen: Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. Biochem Biophys Res Commun 335, 1095-1101 (2005) (Pubitemid 41215531)
45. S. Tatsumi, K. Ishii, N. Amizuka, M. Li, T. Kobayashi, K. Kohno, M. Ito, S. Takeshita, K. Ikeda: Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab 5, 464-475 (2007) (Pubitemid 46825494)
46. G. Karsenty, E. F. Wagner: Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2, 389-406 (2002) (Pubitemid 34436569)
47. C. A. O'Brien, T. Nakashima, H. Takayanagi: Osteocyte control of osteoclastogenesis, Bone 54, 258-263 (2012)
48. S. Khosla: Minireview: the OPG/RANKL/RANK system. Endocrinology 142, 5050-5055 (2001) (Pubitemid 33131929)
49. J. M. Blair, H. Zhou, M. J. Seibel, C. R. Dunstan: Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol 3, 41-49 (2006) (Pubitemid 43108833)
50. B. F. Boyce, L. Xing: Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473, 139-146 (2008)
51. B. F. Boyce, Z. Yao, L. Xing: Osteoclasts have multiple roles in bone in addition to bone resorption. Crit Rev Eukaryot Gene Expr 19, 171-180 (2009)
52. N. Manabe, H. Kawaguchi, H. Chikuda, C. Miyaura, M. Inada, R. Nagai, Y. Nabeshima, K, Nakamura, A. M. Sinclair, R. H. Scheuermann, M. Kuro-o: Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 167, 2625-2631 (2001) (Pubitemid 32768891)
53. M. N. Weitzmann, S. Cenci, J. Haug, C. Brown, J. Di Persio, R. Pacifici: B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem 78, 318-324 (2000) (Pubitemid 30415907)
54. R. P. Heaney: Is the paradigm shifting? Bone 33, 457-465 (2003) (Pubitemid 37222371)
55. International Osteoporosis Foundation. Facts and statistics about osteoporosis and its impact, cited 2011-01-09. Available from: URL: http://www.iofbonehealth.org/facts-andstatistics.html
56. A. Herrera, A. Lobo-Escolar, J. Mateo, J. Gil, E. Ibarz, L. Gracia: Male osteoporosis: A review. World J Orthop 18, 223-234 (2012)
57. P. Sambrook, C. Cooper: Osteoporosis. Lancet 17, 367(9527):2010-8 (2006). (Pubitemid 43867702)
58. Erratum in: Lancet 1, 368(9529):28 (2006)
59. U. Tarantino, R. Iundusi, I. Cerocchi, F. M. Liuni, M. Feola, M. Celi, J. Baldi, E. Gasbarra: Role of the orthopaedic in fragility fracture and in the prevention of a new fracture: SIOT 2009 recommendations. Aging Clin Exp Res 23, 25-27 (2011)
60. B. Obermayer-Pietsch: Genetics of Osteoporosis. Wien Med Wochenschr 156, 162-167 (2006)
61. P. Pietschmann, K. Kerschan-Schindl: Osteoporosis: gender-specific aspects. Wien Med Wochenschr 154, 411-415 (2004) (Pubitemid 39421830)
62. K. P. Chang, J. R. Center, T. V. Nguyen, J. A. Eisman: Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 19, 532-536 (2004) (Pubitemid 41071211)
63. J. K. Lambert, M. Zaidi, J. I. Mechanick: Male osteoporosis: epidemiology and the pathogenesis of aging bones. Curr Osteoporos Rep 9, 229-236 (2011)
64. B. Z. Leder, K. M. LeBlanc, D. A. Schoenfeld, R. Eastell, J. S. Finkelstein: Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88, 204-210 (2003) (Pubitemid 36115166)
65. S. Khosla: Role of Hormonal Changes in the Pathogenesis of Osteoporosis in Men. Calcif Tissue Int 75, 110-113 (2004) (Pubitemid 39166210)
66. R. Pacifici: Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11, 1043-1051 (1996) (Pubitemid 26321353)
67. S. Qiu, D. S. Rao, S. Palnitkar, A. M. Parfitt: Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone 31, 313-318 (2002) (Pubitemid 34822826)
68. E. Seeman, P. D. Delmas: Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 354, 2250-2261 (2006)
69. J. Pfeilschifter, R. Koditz, M. Pfohl, H. Schatz: Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23, 90-119 (2002) (Pubitemid 34185307)
70. U. Tarantino, I. Cerocchi, A. Scialdoni, L. Saturnino, M. Feola, M. Celi, F. M. Liuni, G. Iolascon, E. Gasbarra: Bone healing and osteoporosis. Aging Clin Exp Res 23, 62-64 (2011)
71. B. L. Riggs, A. M. Parfitt: Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20, 177-184 (2005)
72. R. Nuti, M. L. Brandi, G. Isaia, U. Tarantino, S. Silvestri, S. Adami: New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures. J Endocrinol Invest 32, 783-788 (2009)
73. U. Tarantino, A. Capone, M. Planta, M. D'Arienzo, G. Letizia Mauro, A. Impagliazzo, A. Formica, F. Pallotta, V. Patella, A. Spinarelli, U. Pazzaglia, G. Zarattini, M. Roselli, G. Montanari, G. Sessa, M. Privitera, C. Verdoia, C. Corradini, M. Feola, A. Padolino, L. Saturnino, A. Scialdoni, C. Rao, G. Iolascon, M. L. Brandi, P Piscitelli: The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther 12(6):R226 (2010)
74. J. J. Silver, T. A. Einhorn: Osteoporosis and aging: Current update. Clin Orthop 316, 10-20 (1995)
75. S. L. Teitelbaum: Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc Natl Acad Sci USA 101, 16711-16712 (2004) (Pubitemid 39601302)
76. S. Theoleyre, Y. Wittrant, S. K. Tat, Y. Fortun, F. Redini, D. Heymann: The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15, 457-475 (2004) (Pubitemid 39550455)
77. M. N. Weitzmann, R. Pacifici: Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116, 1186-1194 (2006)
78. D. Mirosavljevic, J. M. Quinn, J. Elliott, N. J. Horwood, T. J. Martin, M. T. Gillespie: T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis. J Bone Miner Res 18, 984-993 (2003) (Pubitemid 37294934)
79. H. Takayanagi, K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, K. Nakamura, T. Taniguchi: T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-gamma. Nature 408, 600-605 (2000)
80. F. Di Rosa, R. Pabst: The bone marrow: a nest for migratory memory T cells. Trends Immunol 26, 360-366 (2005) (Pubitemid 40835841)
81. S. Cenci, G. Toraldo, M. N. Weitzmann, C. Roggia, Y. Gao, W. P. Qian, O. Sierra, R. Pacifici: Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA 100, 10405-10410 (2003) (Pubitemid 37071891)
82. P. D'Amelio, A. Grimaldi, S. Di Bella, S. Z. Brianza, M. A. Cristofaro, C. Tamone, G. Giribaldi, D. Ulliers, G. P. Pescarmona, G. Isaia: Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43, 92-100 (2008)
83. K. Sato, A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, D. J. Cua, H. Takayanagi: Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203, 2673-2682 (2006) (Pubitemid 44833343)
84. V. S. Nikolaou, N. Efstathopoulos, G. Kontakis, N. K. Kanakaris, P. V. Giannoudis: The influence of osteoporosis in femoral fracture healing time. Injury 40, 663-668 (2009)
85. P. Geusens, W. F. Lems: Osteoimmunology and osteoporosis. Arthritis Res Ther 13, 242 (2011)
86. P. Kolar, K. Schmidt-Bleek, H. Schell, T. Gaber, D. Toben, G. Schmidmaier, C. Perka, F. Buttgereit, G. N. Duda: The early fracture hematoma and its potential role in fracture healing. Tissue Eng. Part B Rev 16, 427-344 (2010)
87. B. McKibbin: The biology of fracture healing in long bones. J Bone Joint Surg Br 60, 150-162 (1978) (Pubitemid 8356852)
88. A. J. Aho: Electron microscopic and histological observations on fracture repair in young and old rats. Acta Pathol Microbiol Scand 184, 1-95 (1966)
89. E. Tsiridis, N. Upadhyay, P. Giannoudis: Molecular aspects of fracture healing: which are the important molecules? Injury 38, 11-25 (2007)
90. A. Lenz, G. A. Franklin, W. G. Cheadle: Systemic inflammation after trauma. Injury 38, 1336-1345 (2007) (Pubitemid 350192404)
91. E. Tsiridis, P. V. Giannoudis: Transcriptomics and proteomics: advancing the understanding of genetic basis of fracture healing. Injury 37, 13-19 (2006)
92. L. C. Gerstenfeld, T. J. Cho, T. Kon, T. Aizawa, A. Tsay, J. Fitch, G. L. Barnes, D. T. Graves, T. A. Einhorn: Impaired fracture healing in the absence of TNF-alpha signalling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 18, 1584-1592 (2003) (Pubitemid 37022916)
93. M. G. Giganti, F. Liuni, M. Celi, E. Gasbarra, R. Zenobi, I. Tresoldi, A. Modesti, R. Bei, U. Tarantino: Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. J Biol Regul Homeost Agents 26, 671-680 (2012)
94. H. Y. Chung, M. Cesari, S. Anton, E. Marzetti, S. Giovannini, A. Y. Seo, C. Carter, B. P. Yu, C. Leeuwenburgh: Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8, 18-30 (2009)
95. R. P. Tracy: Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metab Disord 27, 29-34 (2003)
96. E. Jimi, I. Nakamura, L. T. Duong, T. Ikebe, N. Takahashi, G. A. Rodan, T. Suda: Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247, 84-93 (1999) (Pubitemid 29393964)
97. L. C. Hofbauer, D. L. Lacey, C. R. Dunstan, T. C. Spelsberg, B. L. Riggs, S. Khosla: Interleukin-1 and tumor necrosis factor-a, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25, 255-259 (1999) (Pubitemid 29406050)
98. J. Lorenzo, M. Horowitz, Y. Choi: Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29, 403-440 (2008). (Pubitemid 351831507)
99. T. Kon, T. J. Cho, T. Aizawa, M. Yamazaki, N. Nooh, D. T. Graves, L. C. Gerstenfeld, T. A. Einhorn: Expression of osteoprotegerin, receptor activator of NF-kB ligand (osteoprotegrin ligand) and related pro-inflammatory cytokines during fracture healing. J Bone Miner Res 16, 1004-1014 (2001) (Pubitemid 32467144)
100. C. Sfeir, L. Ho, B. A. Doll, K. Azari, J. O. Hollinger: Fracture repair. In: Lieberman, J. R., and Friedlaender, G. E., eds. Bone Regeneration and Repair. Totowa, NJ: Humana Press, 21-44 (2005)
101. J. S. Lee, C. H. Ryu, N. H. Moon, S. J. Kim, S. Y. Park, K. T. Suh: Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. Arch Orthop Trauma Surg 129, 711-718 (2009)
102. X. Yang, B. F. Ricciardi, A. Hernandez-Soria, Y. Shi, N. P. Camacho, M. Bostrom: Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41, 928-936 (2007) (Pubitemid 350116738)
103. A. Wallace, T. E. Cooney, R. Englund, J. D. Lubahn: Effects of interleukin-6 ablation on fracture healing in mice. J Orthop Res 29, 1437-1442 (2011)
104. S. J. Moon, I. E. Ahn, H. Jung, H. Yi, J. Kim, Y. Kim, S. K. Kwok, K. S. Park, J. K. Min, S. H. Park, H. Y. Kim, J. H. Ju: Temporal differential effects of proinflammatory cytokines on osteoclastogenesis. Int J Mol Med 31, 769-777 (2013)
105. M. Baud'huin, F. Lamoureux, L. Duplomb, F. Rédini, D. Heymann: RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases. Cell Mol Life Sci 64, 2334-2350 (2007) (Pubitemid 47402577)
106. A. E. Kearns, S. Khosla, P. J. Kostenuik: Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29, 155-192 (2008) (Pubitemid 351519689)
107. R. Gruber: Cell biology of osteoimmunology. Wien Med Wochenschr 160, 438-445 (2010)
108. H. Takayanagi: Inflammatory bone destruction and osteoimmunology. J Periodontal Res 40, 287-293 (2005) (Pubitemid 40977302)
109. S. Theoleyre, Y. Wittrant, S. K. Tat, Y. Fortun, F. Redini, D. Heymann: The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15, 457-475 (2004) (Pubitemid 39550455)
110. M. Rauner, W. Sipos, P. Pietschmann: Osteoimmunology. Int Arch Allergy Immunol 143, 31-48 (2007) (Pubitemid 46625234)
111. E. Tsuda, M. Goto, S. Mochizuki, K. Yano, F. Kobayashi, T. Morinaga, K. Higashio: Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234, 137-142 (1997) (Pubitemid 27267548)
112. J. Caetano-Lopes, H. Canhão, J. E. Fonseca: Osteoimmunology-the hidden immune regulation of bone. Autoimmun Rev 8, 250-255 (2009)
113. Y. Y. Guo, N. Z. Wang, S. Zhao, L. X. Hou, Y. B. Xu, N. Zhang: Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis. Chin Med J 126, 850-854 (2013)
114. T. Taniguchi, T. Matsumoto, H. Shindo: Changes of serum levels of osteocalcin, alkaline phosphatase, IGF-I and IGF-binding protein-3 during fracture healing. Injury 34, 477-479 (2003) (Pubitemid 36794227)
115. L. Xian, X. Wu, L. Pang, M. Lou, C. J. Rosen, T. Qiu, J. Crane, F. Frassica, L. Zhang, J. P. Rodriguez, J. Xiaofeng, Y. Shoshana, X. Shouhong, E. Argiris, W. Mei, C. Xu: Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18, 1095-1101 (2012)
116. P. M. Mountziaris, A. G. Mikos: Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14, 179-186 (2008) (Pubitemid 351839215)
117. L. Marzocchella, M. Fantini, M. Benvenuto, L. Masuelli, I. Tresoldi, A. Modesti, R. Bei: Dietary flavonoids: molecular mechanisms of action as antiinflammatory agents. Recent Pat Inflamm Allergy Drug Discov 5, 200-220 (2011)
118. L. Masuelli, L. Marzocchella, C. Focaccetti, I. Tresoldi, C. Palumbo, V. Izzi, M. Benvenuto, M. Fantini, F. Lista, U. Tarantino, A. Modesti, F. Galvano, R. Bei: Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis. Front Biosci (Landmark Ed) 1, 498-508 (2012)
119. C. H. Byun, J. M. Koh, D. K. Kim, S. I. Park, K. U. Lee, G. S. Kim: Alpha-lipoic acid inhibits TNF-alpha-induced apoptosis in human bone marrow stromal cells. J Bone Miner Res 20, 1125-1135 (2005) (Pubitemid 40863800)
120. L. Masuelli, L. Marzocchella, A. Quaranta, C. Palumbo, G. Pompa, V. Izzi, A. Canini, A. Modesti, F. Galvano, R. Bei: Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Front Biosci (Landmark Ed) 1, 1060-1068 (2011)
121. M. Renis, L. Calandra, C. Scifo, B. Tomasello, V. Cardile, L. Vanella, R. Bei, L. La Fauci, F. Galvano: Response of cell cycle/stress-related protein expression and DNA damage upon treatment of CaCo2 cells with anthocyanins. Br J Nutr 100, 27-35 (2008)
122. L. Masuelli, M. Benvenuto, M. Fantini, L. Marzocchella, P. Sacchetti, E. Di Stefano, I. Tresoldi, V. Izzi, R. Bernardini, C. Palumbo, M. Mattei, F. Lista, F. Galvano, A. Modesti, R. Bei: Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents 27, 105-119 (2013)
123. M. Benvenuto, M. Fantini, L. Masuelli, E. De Smaele, F. Zazzeroni, I. Tresoldi, G. Calabrese, F, Galvano, A. Modesti, R. Bei: Inhibition of ErbB receptors, Hedgehog and NF-kappaB signaling by polyphenols in cancer. Front Biosci (Landmark Ed) 1, 1290-1310 (2013)
124. A. Scalbert, C. Manach, C. Morand, C. Rémésy, L. Jiménez: Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45, 287-306 (2005) (Pubitemid 41657352)
125. S. A. Tanumihardjo: Vitamin a and bone health: the balancing act. J Clin Densitom 16, 414-419 (2013)
126. S. A. Sheweita, K. I. Khoshhal: Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 8, 519-525 (2007) (Pubitemid 47603416)
127. S. Mohan, A. Kapoor, A. Singgih, Z. Zhang, T. Taylor, H. Yu, R. B. Chadwick, Y. S. Chung, L. R. Donahue, C. Rosen, G. C Crawford, J. Wergedal, D. J. Baylink: Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency. J Bone Miner Res 20, 1597-1610 (2005) (Pubitemid 41243549)
128. B. Sarisözen, K. Durak, G. Dincer, O. F. Bilgen: The effects of vitamins E and C on fracture healing in rats. J Int Med Res 30, 309-313 (2002) (Pubitemid 34823309)
129. N. Binkley, D. Krueger: Hypervitaminosis A and bone. Nutr Rev 58, 138-144 (2000) (Pubitemid 30390256)
130. R. Bei, A. Frigiola, L. Masuelli, L. Marzocchella, I. Tresoldi, A. Modesti, F. Galvano: Effects of omega-3 polyunsaturated fatty acids on cardiac myocyte protection. Front Biosci (Landmark Ed) 1, 1833-1843 (2011)
131. L. Masuelli, P. Trono, L. Marzocchella, M. A. Mrozek, C. Palumbo, M. Minieri, F. Carotenuto, R. Fiaccavento, A. Nardi, F. Galvano, P. Di Nardo, A. Modesti, R. Bei: Intercalated disk remodeling in deltasarcoglycandeficient hamsters fed with an alphalinolenic acid-enriched diet. Int J Mol Med 21, 41-48 (2008) (Pubitemid 351222866)
132. R. Fiaccavento, F. Carotenuto, M. Minieri, L. Masuelli, A. Vecchini, R. Bei, A. Modesti, L. Binaglia, A. Fusco, A. Bertoli, G. Forte, L. Carosella, P. Di Nardo: Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters. Am J Pathol 169, 1913-1924 (2006) (Pubitemid 351181954)
133. U. N. Das: Essential fatty acids and osteoporosis. Nutrition 16, 386-390 (2000) (Pubitemid 30227700)
134. H. Sabour, B. Larijani, M. R. Vafa, M. R. Hadian, R. Heshmat, H. A. Meybodi, H. E. Razavi, A. N. Javidan, F. Shidfar: The effects of n-3 fatty acids on inflammatory cytokines in osteoporotic spinal cord injured patients: A randomized clinical trial. J Res Med Sci 17, 322-327 (2012)
135. U. H. Lerner: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 85, 596-607 (2006) (Pubitemid 44085948)
136. B. A. Watkins, Y. Li, M. F. Seifert: Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: Actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 17, 282-289 (2006)
137. M. Yamaguchi. Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis. Mol Cell Biochem 366, 201-221 (2012)
138. G. G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, J. A. Gustafsson. Endocrinology 138, 863-870 (1997)
139. M. Yamaguchi: Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 126, 1117-1137 (2006) (Pubitemid 44715696)
140. H. S. Hsieh, J. M. Navia: Zinc deficiency and bone formation in guinea pig alveolar implants. J Nutr 110, 1581-1588 (1980) (Pubitemid 11192820)
141. A. Igarashi, M. Yamaguchi: Increase in bone protein components with healing rat fractures: enhancement by zinc treatment. Int J Mol Med 4, 615-620 (1999)
142. S. Uchiyama, M. Yamaguchi: Genistein and zinc synergistically enhance gene expression and mineralization in osteoblastic MC3T3-E1 cells. Int J Mol Med 19, 213-220 (2007)
143. M. J. Hoi, E. J. Park, H. J. Jo: Relationship of nutrient intakes and bone mineral density of elderly women in Daegu, Korea. Nutr Res Pract 1, 328-334 (2007)
144. M. Sakuma, N. Endo, T. Oinuma, T. Hayami, E. Endo, T. Yazawa, K. Watanabe, S. Watanabe: Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 17, 1608-1614 (2006) (Pubitemid 44477620)